Paeds Vivas · genetics-dysmorphology-and-metabolism
Inborn errors presenting with neurological regression — branching viva
Branching viva on the inborn errors of metabolism that present with neurological regression: recognising regression as a red flag, grouping the disorders by affected pathway, deploying a tiered metabolic-and-genomic workup, identifying the treatable subset, and matching the disease-modifying therapy to central-nervous-system involvement.
On this page & tools
Target exams
Opening branch — the regressing toddler
A two-year-old who was speaking in two-word phrases and running has stopped speaking and begun to stumble over four months. The candidate must first confirm that this is true regression - loss of previously acquired skills - distinguished from delay, plateau, and a static deficit by a meticulous developmental history anchored to earlier milestones. The candidate states that regression mandates a search for a progressive and potentially treatable cause at speed, because the commonest error is reading a static deficit as progressive or, conversely, labelling a treatable IEM as cerebral palsy. [3]
The examiner probes the classification. The candidate groups the regressing IEM by affected pathway - intoxicating small-molecule, energy or mitochondrial, storage or lysosomal, and lipid-traffic and metal - and explains that the pathway predicts the bedside pattern, the first-line test, and whether a disease-modifying therapy exists. The teaching point is that a treatable subset spans every group, which is why the governing principle is to exclude the treatable IEM before labelling a child degenerative. [1] [3]
You have read the opening of this viva. The complete unit — every section and its primary-source references — is part of the Paediatrics Fellowship fellowship atlas.
References5Show ledgerHide ledger
- [1]van Karnebeek CD, Stockler S. Treatable inborn errors of metabolism causing intellectual disability: a systematic literature review. Mol Genet Metab, 2012.PMID 22212131
- [2]van Karnebeek CD, Shevell M, Zschocke J, Moeschler JB, Stockler S. The metabolic evaluation of the child with an intellectual developmental disorder: diagnostic algorithm for identification of treatable causes and new digital resource. Mol Genet Metab, 2014.PMID 24518794
- [3]Moeschler JB, Shevell M Comprehensive evaluation of the child with intellectual disability or global developmental delays. Pediatrics, 2014.PMID 25157020
- [4]Engelen M, Kemp S, de Visser M, et al. X-linked adrenoleukodystrophy (X-ALD): clinical presentation and guidelines for diagnosis, follow-up and management. Orphanet J Rare Dis, 2012.PMID 22889154
- [5]Pearson TS, Akman C, Hinton VJ, Engelstad K, De Vivo DC. Phenotypic spectrum of glucose transporter type 1 deficiency syndrome (Glut1 DS). Curr Neurol Neurosci Rep, 2013.PMID 23443458